These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36644206)

  • 1. Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort.
    Lima IR; Tada MT; Oliveira TGM; Jannes CE; Bensenor I; Lotufo PA; Santos RD; Krieger JE; Pereira AC
    Atheroscler Plus; 2022 Aug; 49():47-55. PubMed ID: 36644206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
    Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE
    Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polygenic Risk Score for Low-Density Lipoprotein Cholesterol Is Associated With Risk of Ischemic Heart Disease and Enriches for Individuals With Familial Hypercholesterolemia.
    Wu H; Forgetta V; Zhou S; Bhatnagar SR; Paré G; Richards JB
    Circ Genom Precis Med; 2021 Feb; 14(1):e003106. PubMed ID: 33440130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations.
    Olmastroni E; Gazzotti M; Arca M; Averna M; Pirillo A; Catapano AL; Casula M;
    J Am Heart Assoc; 2022 Apr; 11(7):e023668. PubMed ID: 35322671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical atherosclerosis determined by coronary artery calcium deposition in patients with clinical familial hypercholesterolemia.
    Borg SÁ; Sørensen Bork C; Skjelbo Nielsen MR; Jóanesarson J; Zaremba T; Lolas IBY; Lundbye-Christensen S; Søgaard P; Berg Schmidt E; Joensen AM
    Atheroscler Plus; 2022 Dec; 50():65-71. PubMed ID: 36643796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic contribution for familial hypercholesterolemia (FH).
    Medeiros AM; Bourbon M
    Curr Opin Lipidol; 2021 Dec; 32(6):392-395. PubMed ID: 34751168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
    D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
    J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia.
    Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA
    J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
    Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
    Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.
    Futema M; Shah S; Cooper JA; Li K; Whittall RA; Sharifi M; Goldberg O; Drogari E; Mollaki V; Wiegman A; Defesche J; D'Agostino MN; D'Angelo A; Rubba P; Fortunato G; Waluś-Miarka M; Hegele RA; Aderayo Bamimore M; Durst R; Leitersdorf E; Mulder MT; Roeters van Lennep JE; Sijbrands EJ; Whittaker JC; Talmud PJ; Humphries SE
    Clin Chem; 2015 Jan; 61(1):231-8. PubMed ID: 25414277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia.
    Tromp TR; Cupido AJ; Reeskamp LF; Stroes ESG; Hovingh GK; Defesche JC; Schmidt AF; Zuurbier L
    Atherosclerosis; 2022 Jan; 340():61-67. PubMed ID: 34774301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of polygenic cause in Korean patients with familial hypercholesterolemia - A study supported by Korean Society of Lipidology and Atherosclerosis.
    Kwon M; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo J; Hur SH; Jeong JO; Jang Y; Lee SH; Lee JH
    Atherosclerosis; 2015 Sep; 242(1):8-12. PubMed ID: 26160041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
    Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S;
    Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolaemia: A Propensity Score Analysis.
    Mickiewicz A; Futema M; Ćwiklinska A; Kuchta A; Jankowski M; Kaszubowski M; Chmara M; Wasąg B; Fijałkowski M; Jaguszewski M; Humphries SE; Gruchała M
    Life (Basel); 2020 May; 10(5):. PubMed ID: 32443900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenic Markers in Patients Diagnosed of Autosomal Dominant Hypercholesterolemia in Catalonia: Distribution of Weighted LDL-c-Raising SNP Scores and Refinement of Variant Selection.
    Martín-Campos JM; Ruiz-Nogales S; Ibarretxe D; Ortega E; Sánchez-Pujol E; Royuela-Juncadella M; Vila À; Guerrero C; Zamora A; Soler I Ferrer C; Arroyo JA; Carreras G; Martínez-Figueroa S; Roig R; Plana N; Blanco-Vaca F; Xarxa d'Unitats de Lípids I Arteriosclerosi Xula
    Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32942679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
    Trinder M; Li X; DeCastro ML; Cermakova L; Sadananda S; Jackson LM; Azizi H; Mancini GBJ; Francis GA; Frohlich J; Brunham LR
    J Am Coll Cardiol; 2019 Jul; 74(4):512-522. PubMed ID: 31345425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children with hypercholesterolemia of unknown cause: Value of genetic risk scores.
    Sjouke B; Tanck MWT; Fouchier SW; Defesche JC; Hutten BA; Wiegman A; Kastelein JJP; Hovingh GK
    J Clin Lipidol; 2016; 10(4):851-859. PubMed ID: 27578116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.
    Paquette M; Chong M; Thériault S; Dufour R; Paré G; Baass A
    J Clin Lipidol; 2017; 11(3):725-732.e5. PubMed ID: 28456682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives.
    Cupido AJ; Tromp TR; Hovingh GK
    Curr Opin Lipidol; 2021 Apr; 32(2):112-116. PubMed ID: 33560669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
    Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
    Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.